The new esketamine nasal spray represents a promising treatment for one third of people with resistant depression, which does not respond to common antidepressants, and is administered under the supervision of doctors in healthcare facilities. #deprese #psychoterapie #esketamin (translated)
Třetině lidí na depresi nezaberou běžné léky. Novou nadějí je sprej na bázi ketaminu
